Sarissa Capital Master Fund II LP's Net Worth
$0
Estimate Recalculated Sep 8, 2024 07:39PM EST
Who is Sarissa Capital Master Fund II LP?
Sarissa Capital Master Fund II LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Iterum Therapeutics plc, and Regulus Therapeutics Inc..
SEC CIK
Sarissa Capital Master Fund II LP's CIK is 0001811636
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Iterum Therapeutics plc (ITRM) Snapshot price: $1.12
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$2.43 | -$50,007,284.23 | 20.62M |
Feb 11 - Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||